1. SNAP-25 in Major Psychiatric Disorders: A Review
- Author
-
B. Matthew Fagan, Peter M. Thompson, and Katherine Najera
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Synaptic cleft ,Synaptosomal-Associated Protein 25 ,business.industry ,General Neuroscience ,Mental Disorders ,Alcohol use disorder ,medicine.disease ,03 medical and health sciences ,030104 developmental biology ,0302 clinical medicine ,Schizophrenia ,medicine ,Dementia ,Attention deficit hyperactivity disorder ,Major depressive disorder ,Autism ,Animals ,Humans ,Bipolar disorder ,Psychiatry ,business ,030217 neurology & neurosurgery - Abstract
Synaptosomal Associated Protein-25 kilodaltons (SNAP-25) is an integral member of the SNARE complex. This complex is essential for calcium-triggered synaptic vesicular fusion and release of neurotransmitters into the synaptic cleft. In addition to neurotransmission, SNAP-25 is associated with insulin release, the regulation of intracellular calcium, and neuroplasticity. Because of SNAP-25's varied and crucial biological roles, the consequences of changes in this protein can be seen in both the central nervous system and the periphery. In this review, we will look at the published literature from human genetic, postmortem, and animal studies involving SNAP-25. The accumulated data indicate that SNAP-25 may be linked with some symptoms associated with a variety of psychiatric disorders. These disorders include bipolar disorder, schizophrenia, major depressive disorder, attention deficit hyperactivity disorder, autism, alcohol use disorder, and dementia. There are also data suggesting SNAP-25 may be involved with non-psychiatric seizures and metabolic disorders. We believe investigation of SNAP-25 is important for understanding both normal behavior and some aspects of the pathophysiology of behavior seen with psychiatric disorders. The wealth of information from both animal and human studies on SNAP-25 offers an excellent opportunity to use a bi-directional research approach. Hypotheses generated from genetically manipulated mice can be directly tested in human postmortem tissue, and, conversely, human genetic and postmortem findings can improve and validate animal models for psychiatric disorders.
- Published
- 2018